GlassScriptPhysician profile
Kip Dorsey
NPI 1508063074
$8,246.43
in general payments reported to CMS, 2019-2025
8 companies · $1,295 in 2025
The $1,295 reported for 2025 was more than what 75% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,090 · 2020: $342 · 2021: $640 · 2022: $1,116 · 2023: $2,282 · 2024: $1,481 · 2025: $1,295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,142 · Education: $1,000 · Food and Beverage: $917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,141.56 |
| Education | $1,000.00 |
| Food and Beverage | $916.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,984.38 | 2019-2025 | Da Vinci Surgical System, Davinci Xi |
| Davol INC. | $1,651.68 | 2020-2023 | Phasix Mesh |
| Allergan, INC. | $176.93 | 2019-2022 | |
| Medtronic, INC. | $166.67 | 2025 | Transorb |
| Myriad Genetic Laboratories, INC. | $87.20 | 2021 | |
| Abbvie INC. | $86.14 | 2025 | |
| Smith+Nephew, INC. | $70.43 | 2025 | Collagenase Santyl |
| Becton, Dickinson and Company | $23.00 | 2023 | Phasix Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kip Dorsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.